An emerging body of literature demonstrates differences in the gut microbiome (GMB) of
patients with major depressive disorder (MDD) compared to healthy controls (HC), as well …

Background Growing attention has been paid to the field of gut microbiota for mental
disorders over the last decade. However, to our knowledge, no studies have conducted …

A promising new treatment approach for major depressive disorder (MDD) targets the
microbiota-gut-brain (MGB) axis, which is linked to physiological and behavioral functions …

Mental disorders and neurological diseases are becoming a rapidly increasing medical
burden. Although extensive studies have been conducted, the progress in developing …

Major depression is one of the leading causes of disability, morbidity, and mortality
worldwide. The brain–gut axis functions are disturbed, revealed by a dysfunction of the …

The accumulating knowledge of the host-microbiota interplay gives rise to the microbiota-gut-
brain (MGB) axis. The MGB axis depicts the interkingdom communication between the gut …

Major depressive disorder is a leading cause of disability worldwide. Because conventional
therapies are ineffective in many patients, novel strategies are needed to overcome …

Background New research supports an integrated approach to treating depression, and
lifestyle modifications should be a regular component of both preventative and treatment …

Background: A growing body of research has shown that consumption of probiotics can
improve symptoms associated with mood and anxiety disorders through activity of the gut …

The gut microbiota are being called the human “second brain,” as they play a key role in the
regulation of the central nervous system (CNS). Recent findings provide strong evidence for …